Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

212 trials

NCT04846959
Recruiting
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
Not applicable · United States · 2 sites
Registry update: 17 Jul 2025
NCT04772079
Recruiting
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
Phase 3 · Argentina, Australia, Brazil, Canada, Germany, Spain, France, United Kingdom, Japan, South Korea, Mexico, Poland, Romania · 62 sites
Registry update: 26 Oct 2026
NCT04638647
Recruiting
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Phase 4 · Belgium, Bulgaria, Czechia, Germany, Denmark, Spain, France, Italy, Poland, Portugal · 48 sites
Registry update: 9 Nov 2026
NCT04537689
Recruiting
Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
Phase 4 · Singapore · 1 site
Registry update: 25 Nov 2022
NCT04402086
Recruiting
Rheumatology Patient Registry and Biorepository
Not applicable · United States · 1 site
Registry update: 13 Feb 2026
NCT04334031
Recruiting
Deployment o the Multidisciplinary Prospective Cohort Imminent
Not applicable · France · 1 site
Registry update: 5 May 2026
NCT04800289
Recruiting
Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/Dermatologist
Not applicable · France · 1 site
Registry update: 16 Mar 2021
NCT04465838
Recruiting
Chinese Psoriasis Real World Evidence Research
Not applicable · China · 29 sites
Registry update: 5 Jan 2024
NCT04372277
Recruiting
Taltz in Combination With Enstilar for Psoriasis
Phase 4 · United States · 1 site
Registry update: 4 May 2020
NCT04347473
Recruiting
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
Phase 4 · United States · 1 site
Registry update: 15 Apr 2020
NCT03768271
Recruiting
APACHE Cohort (A Psoriatic Arthritis CoHort)
Not applicable · France · 3 sites
Registry update: 27 Apr 2026
NCT04191395
Recruiting
Evolution and Treatments of Chronic Inflammatory Systemic Diseases
Not applicable · France · 1 site
Registry update: 27 Nov 2024
NCT04036188
Recruiting
Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis
Early phase 1 · United States · 1 site
Registry update: 19 Feb 2026
NCT04119102
Recruiting
Duobrii in Combination With Biologics
Phase 4 · United States · 1 site
Registry update: 30 Apr 2020
NCT03816345
Recruiting
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Phase 1 · Canada, United States · 52 sites
Registry update: 5 Oct 2026
NCT04014413
Recruiting
Safety and Efficacy of Fecal Microbiota Transplantation
Not applicable · Hong Kong · 1 site
Registry update: 22 Aug 2024
NCT04170244
Recruiting
Skin Microbial Ecology in Atopic Dermatitis
Not applicable · United States · 1 site
Registry update: 14 Jul 2026
NCT03827876
Recruiting
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
Phase 4 · United States · 1 site
Registry update: 4 Feb 2019
NCT03392337
Recruiting
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
Not applicable · United States · 1 site
Registry update: 30 Jan 2019
NCT03248284
Recruiting
Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons
Not applicable · Denmark · 2 sites
Registry update: 5 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.